Pamicell, Foreigners Net Buy 76,000 Shares... Stock Price -2.9%
Pamisell has ranked among the top searched stocks on 6 days in the past month.
As of 12:30 PM on the 1st, Pamisell is trading at 21,750 KRW, down 2.9% from the previous day. This is a 7.84% decrease compared to August 6. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Today, foreigners have a tentative net purchase of 76,000 shares of Pamisell, while institutions have a net sale of 1,000 shares. Over the past 5 days, individual investors have net purchased 627,531 shares, while foreigners and institutions have net sold 658,073 shares and net purchased 71,724 shares, respectively.
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- Thought to Be Just a Military Force, but Now Controls 40% of Iran’s Economy... IRGC Even Moves Into Cola Business [Company IRGC]①
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
